Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress.
Journal Title: Pharmacological Reports - Year 2010, Vol 62, Issue 1
Abstract
Endothelin (ET) was first isolated and described by Yanagisawa et al. and has since been described as one of the most potent known vasoconstrictor compounds. ET-1 mediates its effects via two types of receptors, ETA and ETB, which are expressed in the vascular smooth muscle cells, endothelial cells, intestines and brain. Secretion of ET-1 results in long-lasting vasoconstriction, increased blood pressure and, in turn, overproduction of free radicals. As dysregulation of the endothelin system is an important factor in the pathogenesis of several diseases including atherosclerosis, hypertension and endotoxic shock, the ETA and ETB receptors are attractive therapeutic targets for treatment of these disorders. The biosynthesis and release of ET-1 are regulated at the transcriptional level. Studies have shown that p38MAP kinase, nuclear factor kappaB (NF-kappaB), PKC/ERK and JNK/c-Jun all take part in the ROS-activated production of ET-1. Furthermore, administration of ET(A) significantly reduces the generation of free radicals. However, treatment with ETB receptor blockers does not elicit the same effect. Therefore, the effects of endothelin receptor blockers on blood pressure and the generation of free radicals remain debatable. This review summarizes recent investigations into the role of endothelin receptor blockers with respect to the modulation of hemodynamic parameters and the generation of free radicals.
Authors and Affiliations
Aleksandra Piechota, Andrzej Polańczyk, Anna Gorąca
Keywords
Related Articles
- EP ID EP134263
- DOI -
- Views 96
- Downloads 0
Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
Pituitary adenylate cyclase activating polypeptide (PACAP), vasoactiveintestinal peptide (VIP) and peptide histidine-isoleucine (PHI), are structurally related endogenouspeptides widely expressed in the central and perip...
Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain.
Three derivatives of dihydrofuran-2-one (L-PP, L-PP1, and L-SAL) were administered by intraperitoneal injection and their analgesic activity was assayed in several models of pain. The activity of these derivatives were t...
Neurochemical Conference 2009. Genetic and molecular biochemistry of neurological diseases in experiment and clinic. Neuroprotective strategy.
Different effects of nitric oxide synthase inhibitors on convulsions induced by nicotine in mice.
Acute intraperitoneal (ip) administration of N(G)-nitro-L-arginine (NNA, 10, 20 and 40 mg/kg), a non-selective nitric oxide synthase (NOS) inhibitor, significantly and dose-dependently decreased the incidence of convulsi...
Comparison of the pharmacokinetics of paracetamol from two generic products in patients after total gastric resection.
Gastrectomy leads to pathophysiological changes within the alimentary tract, which may affect drug absorption and pharmacokinetic parameters (PK). The need to apply orally administered analgesics in this group of patient...